Population
MC-3T3 preosteoblasts and primary calvarial osteoblasts from IGFBP-2(-/-) mice
Comparison
IGFBP-2 modulation vs Control cultures
Design
Preclinical
Authors
Loading...
IGFBP-2 pathway merits exploration for osteoporosis therapy; leaves open clinical translation from preclinical models.
IGFBP-2 directly stimulates osteoblast differentiation via interaction between its heparin-binding domain-1 and RPTPβ, highlighting a key mechanism for bone mass regulation.
Xi et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: